2007
DOI: 10.1007/978-1-59745-492-6_9
|View full text |Cite
|
Sign up to set email alerts
|

Fast Drug Application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…High-velocity piezoelectric translators are currently used to overcome this limitation; however, they often suffer from resonant “ringing” after very brief excursions, which produces unwanted fluidic oscillations (Jonas, 1995; Clements, 1997; Mozrzymas et al, 2007), they require the use of high voltages, which requires electrical shielding to prevent additional noise contributions (Jonas, 1995; Clements, 1997; Heckmann and Pawlu, 2002), and they have a limited range of motion (typically 20–80 μm), which substantially limits the potential complexity of experimental protocols. Thus, if LGICs are to be studied in vitro under physiologically relevant conditions, an alternate approach is needed.…”
Section: Resultsmentioning
confidence: 99%
“…High-velocity piezoelectric translators are currently used to overcome this limitation; however, they often suffer from resonant “ringing” after very brief excursions, which produces unwanted fluidic oscillations (Jonas, 1995; Clements, 1997; Mozrzymas et al, 2007), they require the use of high voltages, which requires electrical shielding to prevent additional noise contributions (Jonas, 1995; Clements, 1997; Heckmann and Pawlu, 2002), and they have a limited range of motion (typically 20–80 μm), which substantially limits the potential complexity of experimental protocols. Thus, if LGICs are to be studied in vitro under physiologically relevant conditions, an alternate approach is needed.…”
Section: Resultsmentioning
confidence: 99%